Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro

Journal of Veterinary Medical Science

Volumn 72, Issue 6, 2010, Pages 765-771

  Hwang, Shiang Jyi ^a   Yamasaki, Masahiro ^a   Nakamura, Kensuke ^a   Sasaki, Noboru ^a   Murakami, Masahiro ^a   Wickramasekara Rajapakshage, Bandula Kumara ^a   Ohta, Hiroshi ^a   Maede, Yoshimitsu ^a   Takiguchi, Mitsuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Babesia gibsoni; Diminazene aceturate; Drug resistance

Indexed keywords

ANTIPROTOZOAL AGENT; CLINDAMYCIN; DIMINAZENE; DIMINAZENE ACETURATE; DOXYCYCLINE; DRUG DERIVATIVE; METRONIDAZOLE; PENTAMIDINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BABESIA; BABESIOSIS; CELL DIVISION; DOG; DOG DISEASE; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; ERYTHROCYTE; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; PARASITOLOGY;

ANIMALS; ANTIPROTOZOAL AGENTS; BABESIA; BABESIOSIS; CELL DIVISION; CLINDAMYCIN; DIMINAZENE; DOG DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; DRUG RESISTANCE; ERYTHROCYTES; METRONIDAZOLE; PENTAMIDINE;

BABESIA GIBSONI;

EID: 77954251930     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0535     Document Type: Article

References (34)

1. Basselin, M. and Robert-Gero, M. 1998. Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania. Parasitol. Res. 84: 78-83.
2. Bielawski, K., Galicka, A., Bielawska, A. and Sredzińska, K. 2000. Inhibitory effects of pentamidine analogues on protein biosynthesis in vitro. Acta Biochim. Pol. 47: 113-120.
3. Bitonti, A. J., Dumont, J. A. and McCann, P. P. 1986. Characterization of Trypanosoma brucei brucei S-adenosyl-Lmethionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone). Biochem. J. 237: 685-689.
4. Boozer, A. L. and Macintire, D. K. 2003. Canine babesiosis. Vet. Clin. North Small Anim. Pract. 33: 885-904.
5. Coelho, A. C., Beverley, S. M. and Cotrim, P. C. 2003. Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol. Biochem. Parasitol. 130: 83-90.
6. Carter, N. S., Berger, B. J. and Fairlamb, A. H. 1995. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsensensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270: 28153- 28157.
7. Chow, T. Y., Alaoui-Jamali, M. A., Yeh, C., Yuen L. and Griller, D. 2004. The DNA double-stranded break repair protein endo-exonuclease as a therapeutic target for cancer. Mol. Cancer Ther. 3: 911-919.
8. Collett, M. G. 2000. Survey of canine babesiosis in South Africa. J. S. Afr. Vet. Assoc. 71: 180-186.
9. Conrad, P., Thomford, J., Yamane, I., Whiting, J., Bosma, L., Uno, T., Holshuh, H. J. and Shelly, S. 1991. Hemolytic anemia caused by Babesia gibsoni infection in dogs. J. Am. Vet. Med. Assoc. 199: 601-605.
10. Dahl, E. L., Shock, J. L., Shenai, B. R., Gut, J., DeRisi, J. L. and Rosenthal, P. J. 2006. Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob. Agents Chemother. 50: 3124-3131.
11. Farwell, G. E., LeGrand, E. K. and Cobb, C. C. 1982. Clinical observations on Babesia gibsoni and Babesia canis infections in dogs. J. Am. Vet. Med. Assoc. 180: 507-511.
12. Foote, S. J., Thompson, J. K., Cowman, A. F. and Kemp, D. J. 1989. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum. Cell 57: 921-930.
13. Fowler, J. L., Ruff, M. D., Fernau, R. C. and Fursusho, Y. 1972. Babesia gibsoni: chemotherapy in dogs. Am. J. Vet. Res. 33: 1109-1114.
14. +)-ATPase. J. Biol. Chem. 259: 312-317.
15. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M. J., Martin, S. K., Milhous, W. K. and Schlesinger, P. H. 1987. Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
16. Leon, W., Brun, R. and Krassner, S. M. 1977. Effect of Berenil on growth, mitochondrial DNA and respiration of Leishmania tarentolae promastigotes. J. Protozool. 24: 444-448.
17. Macadam, R. F. and Williamson, J. 1972. Drug effects on the fine structure of Trypanosoma rhodesiense: diamidines. Trans. R. Soc. Trop. Med. Hyg. 66: 897-904.
18. Matsuu, A., Koshida, Y., Kawahara, M., Inoue, K., Ikadai, H., Hikasa, Y., Okano, S. and Higuchi, S. 2004. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro. Vet. Parasitol. 124: 9-18.
19. Matsuu, A., Miyamoto, K., Ikadai, H., Okano, S. and Higuchi, S. 2006. Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment. Am. J. Trop. Med. Hyg. 74: 593-597.
20. Matsuu, A., Yamasaki, M., Xuan, X., Ikadai, H. and Hikasa, Y. 2008. In vitro evaluation of the growth inhibitory activities of 15 drugs against Babesia gibsoni (Aomori strain). Vet. Parasitol. 157: 1-8.
21. Newton, B. A. and Le Page, R. W. F. 1968. Interaction of Berenil with trypanosome DNA. Trans. R. Soc. Trop. Med. Hyg. 62: 131-132.
22. Plumb, D. C. 2005. Clindamycin. pp. 183-185. In: Plumb's Veterinary Drug Handbook, 5th ed., Pharmavet Inc., Ames.
23. Plumb, D. C. 2005. Doxycycline. pp. 286-289. In: Plumb's Veterinary Drug Handbook, 5th ed., Pharmavet Inc., Ames.
24. Sakuma, M., Setoguchi, A. and Endo, Y. 2009. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin. J. Vet. Intern. Med. 23: 493-498.
25. Subeki, Matsuura, H., Takahashi, K., Nabeta, K., Yamasaki, M., Maede, Y. and Katakura, K. 2007. Screening of Indonesian medicinal plant extracts for antibabesial activity and isolation of new quassinoids from Brucea javanica. J. Nat. Prod. 70: 1654-1657.
26. Sugimoto, C., Sato, M., Kawazu, S., Kamio, T. and Fujisaki, K. 1991. Purification of merozoites of Theileria sergenti from infected bovine erythrocytes. Parasitol. Res. 77: 129-131.
27. Suzuki, K., Wakabayashi, H., Takahashi, M., Fukushima, K., Yabuki, A. and Endo, Y. 2007. A possible treatment strategy and clinical factors to estimate the treatment response in Babesia gibsoni infection. J. Vet. Med. Sci. 69: 563-568.
28. Tidwell, R. R., Jones, S. K., Naiman, N. A., Berger, L. C., Brake, W. B., Dykstra, C. C. and Hall, J. E. 1993. Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrob. Agents Chemother. 37: 1713-1716.
29. Vega, C. A., Buening, G. M., Green, T. J. and Carson, C. A. 1985. In vitro cultivation of Babesia bigemina. Am. J. Vet. Res. 46: 416-420.
30. Wiesner, J., Reichenberg, A., Heinrich, S., Schlitzer, M. and Jomaa, H. 2008. The plastid-like organelle of Apicomplexan parasites as drug target. Curr. Pharm. Des. 14: 855-871.
31. Wilson, C. M., Serrano, A. E., Wasley, A., Bogenschutz, M. P., Shankar, A. H. and Wirth, D. F. 1989. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 244: 1184-1186.
32. Wulansari, R., Wijaya, A., Ano, H., Hori, Y., Nasu, T., Yamane, S. and Makimura, S. 2003. Clindamycin in the treatment of Babesia gibsoni infections in dogs. J. Am. Anim. Hosp. Assoc. 39: 558-562.
33. Yamasaki, M., Hossain, M. A., Jeong, J. R., Chang, H. S., Satoh, H., Yamato, O. and Maede, Y. 2003. Babesia gibsonispecific isoenzymes related to energy metabolism of the parasite in infected erythrocytes. J. Parasitol. 89: 1142-1146.
34. Yamasaki, M., Takada, A., Yamato, O. and Maede, Y. 2005. Inhibition of Na, K-ATPase activity reduces Babesia gibsoni infection of canine erythrocytes with inherited high K, low Na concentrations. J. Parasitol. 91: 1287-1292.